ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,411Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 680

$1.58M Total Retail Price of All Prescriptions

Rank: 18 out of 680

483 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,741 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$96 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 1,002 756 1 1
MELOXICAM 524 353 2 24
CARVEDILOL 432 331 3 23
CRESTOR 432 268 3 25
BENAZEPRIL HCL 429 328 5 40
SIMVASTATIN 401 332 6 3
NEXIUM 369 230 7 16
TRAMADOL HCL 350 247 8 18
AMLODIPINE BESYLATE-BENAZEPRIL 277 205 9 43
ADVAIR DISKUS 253 125 10 53
OMEPRAZOLE 230 138 11 7
ACTOS 216 145 12 114
FUROSEMIDE 200 150 13 6
HYDROCHLOROTHIAZIDE 183 124 14 9
CELEBREX 180 128 15 90
BENAZEPRIL-HYDROCHLOROTHIAZIDE 177 124 16 164
LYRICA 176 84 17 77
LEVOTHYROXINE SODIUM 171 81 18 2
NAMENDA 167 156 19 35
TAMSULOSIN HCL 165 130 20 34
FENOFIBRATE 165 114 20 66
SPIRIVA 164 77 22 70
PRAVASTATIN SODIUM 164 116 22 10
MECLIZINE HCL 158 116 24 103
SINGULAIR 156 78 25 91
DEXILANT 153 83 26 171
METFORMIN HCL 151 93 27 8
NIASPAN 151 58 27 181
CYMBALTA 150 77 29 46
DIOVAN 142 91 30 31
WARFARIN SODIUM 137 115 31 20
POTASSIUM CHLORIDE 137 77 31 14
LISINOPRIL 135 66 33 5
ZOLPIDEM TARTRATE 130 75 34 17
EXFORGE 129 105 35 151
CLONIDINE HCL 125 97 36 36
ONGLYZA 124 75 37 136
PEN NEEDLE 122 68 38 122
BENICAR 120 59 39 131
DONEPEZIL HCL 118 111 40 27
CLOPIDOGREL 118 86 40 26
LOSARTAN-HYDROCHLOROTHIAZIDE 107 62 42 51
BENICAR HCT 106 56 43 150
ATORVASTATIN CALCIUM 105 62 44 11
JANUVIA 104 70 45 60
SYNTHROID 102 77 46 38
GABAPENTIN 101 68 47 15
AMITIZA 101 50 47 270
TRICOR 100 54 49 98
LANTUS SOLOSTAR 100 43 49 84
EVISTA 99 71 51 135
PANTOPRAZOLE SODIUM 99 43 51 30
HYDROCODONE-ACETAMINOPHEN 99 40 S3 51 4
METHYLPREDNISOLONE 98 57 54 93
VICTOZA 3-PAK 96 49 55 395
FLUTICASONE PROPIONATE 94 53 56 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 66 57 37
EXELON 91 83 58 112
ESCITALOPRAM OXALATE 90 70 59 45
PIOGLITAZONE HCL 88 63 R 60 276
ALLOPURINOL 88 79 60 33
PLAVIX 87 71 62 39
BYSTOLIC 86 42 63 79
MONTELUKAST SODIUM 84 40 64 157
COREG CR 84 74 64 293
LOVAZA 81 16 66 119
CILOSTAZOL 81 73 66 230
AGGRENOX 79 45 68 177
DIOVAN HCT 78 34 69 55
GLIMEPIRIDE 78 78 69 29
AZOR 76 50 71 278
LEVETIRACETAM 75 27 72 120
LUNESTA 72 60 73 252
LOSARTAN POTASSIUM 70 59 74 21
METOPROLOL SUCCINATE 69 57 75 13
PROAIR HFA 69 30 75 67
ULORIC 68 27 77 333
DIGOXIN 65 54 78 58
KOMBIGLYZE XR 62 29 79 426
PAROXETINE HCL 60 48 80 76
NASONEX 59 22 81 197
OLANZAPINE 58 43 82 116
BIDIL 57 47 83 383
RANITIDINE HCL 55 41 84 56
POLYETHYLENE GLYCOL 3350 54 16 85 62
MICARDIS HCT 52 41 86 312
TRAZODONE HCL 50 0 87 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.